Search results
Results from the WOW.Com Content Network
para-Bromomethamphetamine (PBMA; developmental code name V-111), also known as 4-bromomethamphetamine (4-BMA), is a monoaminergic drug of the amphetamine family related to para-chloroamphetamine (PCA; 4-chloroamphetamine).
para-Bromoamphetamine (PBA), also known as 4-bromoamphetamine (4-BA), is an amphetamine derivative which acts as a serotonin-norepinephrine-dopamine releasing agent (SNDRA) and produces stimulant effects. Another related compound is para-bromomethamphetamine (PBMA) known by the codename V-111. [1]
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
para-Bromomethamphetamine (PBMA) References This page was last edited on 12 January 2025, at 01:30 (UTC). Text is available under the Creative Commons Attribution ...
Para-Bromomethamphetamine; Metadata. This file contains additional information, probably added from the digital camera or scanner used to create or digitize it.
In animals, doses of PCA of 0.5 to 5 mg/kg acutely produce a variety of behavioral and neurochemical effects thought to be due to serotonin release. [3] [19] [20] Consequent enhancement of serotonergic signaling, serotonergic effects like myoclonus, the serotonin behavioral syndrome, including tremor, rigidity, Straub tail, hindlimb abduction, lateral head weaving, and reciprocal forepaw ...
para-Chloromethamphetamine (also known as 4-chloromethamphetamine and 4-CMA) is a stimulant that is the N-methyl derivative and prodrug of the neurotoxic drug para-chloroamphetamine (4-CA). [ 1 ] [ 2 ] It has been found to decrease serotonin in rats.
4-Bromofentanyl (para-bromofentanyl) is an opioid analgesic drug that is an analog of fentanyl and has been sold as a designer drug, [1] first identified in Pennsylvania in the US in March 2020. [ 2 ]